BioScience GmbH introduces Hyaprof

It gives us a great pleasure to officially announce the launch of a new product line: Hyaprof.

The newest addition to the product portfolio combines monodensified and polydensified dermal fillers and makes us a manufacturer offering both monophasic and biphasic products for the full spectrum of facial and body applications.


Thanks to the Advanced Thixotropic Technology and Smart Cross-Linking Technology, Hyaprof range demonstrates unique and optimized rheological properties to ensure the improved performance of hyaluronic acid, smooth injection and application as well as seamless dermal integration. Hyaprof fillers show improved cohesivity, viscoelasticity and plasticity to allow homogeneous soft tissue augmentation and rejuvenation, especially for patients with extremely deep folds.


Hyaprof uses dual specialty technology to produce an optimized combination of monodensified and polydensified fillers. The line consists of two products, which can be used individually or in combination in both superficial dermis procedures and deeper injections, depending on the patient’s facial structure and functional needs:


Pure hyaluronic acid: 20mg/mL: a monodensified dermal filler suitable for superficial and submucosal indications. Ideal for the correction of fine lines, crow’s feet, perioral lines, fine forehead lines, thin lips, facial atrophic scars, residual rhytids after botulinum toxin, as well as fine lines of the lateral periocular and infraorbital regions.

Pure hyaluronic acid: 22mg/mL: a polydensified dermal filler with a greater degree of cross-linking, optimal for injections ranging from mid to deep dermis. Ideal for the correction of moderate and deeper lines, tear through deformity, nasolabial wrinkles, glabellar line, lip contouring, philtrum, oral commissures, marionette folds, as well as restoration of facial volume and shape.

Patients’ Concerns

Hyaprof has been created to address the main concerns of patients, such as unnatural look, short-lasting results, as well as pain and post-procedure complications. Allying with these concerns, Hyaprof products are dedicated for patients aiming for a subtle look as well as long-lasting results and can be injected with 30G and 32G needles, which in turn ensures a painless treatment.

Hyaprof dermal fillers line is also accompanied by a skincare system range for post-procedure aftercare.


About BioScience GmbH

Established in 2001, BioScience GmbH is a German manufacturer designing and producing medical devices based on hyaluronic acid. As of today, they are one of the few manufacturers to offer both monophasic and biphasic dermal fillers. Their three product lines – HYAcorp, Genefill and Hyaprof – are certified with the CE mark and used for the full spectrum of facial and body applications in over 77 countries. BioScience’s commitment to innovation and excellence has earned the trust of the most recognized plastic surgeons, dermatologists, as well as a network of over 125 distributors and millions of satisfied patients.

About Hyaprof

Hyaprof, the latest addition to the BioScience product portfolio, is a range of revolutionary monophasic dermal fillers for instant effects, combining monodensified and polydensified properties and being accompanied by a skincare system range for post-procedure aftercare. Hyaprof dermal fillers can be used for both superficial treatment (such as contouring or filling) and deep applications to restore volume and provide augmentation.